NCT03376867View on ClinicalTrials.gov

Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC)

Active, not recruitingOBSERVATIONAL
Enrollment

468

Participants

Timeline

Start Date

November 27, 2017

Primary Completion Date

February 28, 2022

Study Completion Date

December 30, 2024

Conditions
Chronic Pain
Interventions
OTHER

Conditioned pain modulation

Conditioned pain modulation (CPM) protocol consist of evaluating pain during two stimuli test (heat and pressure point), before and after one conditioning stimulus (cold water bath); Blood analyses for biochemistry and genes polymorphisms.

Trial Locations (1)

J1H 5N4

Universite de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Centre for Research of CHUS (CRCHUS)

UNKNOWN

collaborator

CIHR/SPOR - chronic pain network

UNKNOWN

lead

Université de Sherbrooke

OTHER

NCT03376867 - Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC) | Biotech Hunter | Biotech Hunter